Christine Baeder, chief operating officer for generics and biosimilars at Teva USA and newly named chair of the Association for Accessible Medicines, tells this week’s Video Forum about the threats facing the generic pharmaceutical industry and what should be done to counter them. She also discusses the relatively slow pace of adoption of biosimilars in the U.S., the impact of innovative payment models on the marketplace, and the value that generics represent.
Video Forum: Christine Baeder, Teva USA
Latest
Hy-Vee and Coca-Cola donate $5,000 to Iowa Sports Foundation
The donation will benefit the Iowa Sports Foundation’s youth soccer program.
Meijer aids Midwest storm recovery efforts
Meijer partners with the American Red Cross and local groups to give supplies, food, and support to communities hit by severe Midwest storms and tornadoes.
ShopRite launches “We Kick It Here Tour” for summer soccer season
Experiential fan tour to bring soccer-themed events, giveaways and interactive activities to 23 store locations across the Northeast.
H-E-B opens first Dallas County store in Irving
“We’re honored to open our doors to this wonderful community, where our committed H-E-B Partners are ready to earn the loyalty and confidence of local families,” said Juan-Carlos Rück, H-E-B Executive Vice President, North West Food/Drug Operations and Real Estate.